February 13, 2013 — St. Jude Medical has issued a Class I recall for its Amplatzer TorqVue FX Delivery System used in ...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
This short cine loop shows a 3-D/4-D transesophegeal echo (TEE) view of a transcatheter Amplatzer closure device used to ...
February 06, 2013
The PC Trial data presented at TCT 2012 looked at transcather PFO closure vs. medical therapy in preventing cryptogenic ...
November 09, 2012
November 8, 2012 — A clinical trial indicates that using an investigational medical device to close a PFO, or “hole in ...
November 08, 2012
Positive results from the RESPECT Trial of transcatheter patent foramen ovale (PFO) closure vs. standard medical therapy ...
November 05, 2012November 2, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that ...
November 02, 2012
October 30, 2012 — W. L. Gore & Associates responded to initial results reported in St. Jude Medical Inc.’s RESPECT ...
October 30, 2012
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the ...
October 22, 2012
October 19, 2012 — The 24th Transcatheter Cardiovascular Therapeutics (TCT) conference, sponsored by the Cardiovascular ...
October 19, 2012
October 4, 2012 — Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat ...
October 04, 2012June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and ...
June 18, 2012
May 31, 2012 — Occlutech GmbH, a European developer of minimally invasive implants for the treatment of structural heart ...
May 31, 2012
Methodist DeBakey Heart and Vascular Center in Houston, Tex., has leveraged new imaging and interventional technologies ...
May 15, 2012April 24, 2012 - SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO) ...
April 24, 2012
November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement ...
November 15, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now